This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide.View EW key stats
Edwards Lifesciences Corp - EW - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates Edwards Lifesciences Corp as a
Buy with a ratings score of B.
Report Snippet: We rate EDWARDS LIFESCIENCES CORP (EW) a BUY. This is driven by multiple strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.